Identification of the hydroxyl radical and other reactive oxygen species in human neutrophil granulocytes exposed to a fragment of the amyloid beta peptide

Free Radical Research

Volumn 37, Issue 3, 2003, Pages 269-279

  Andersen, Jannike M ^a   Myhre, Oddavar ^a   Aarnes, Halvor ^b   Vestad, Tor Arne ^b   Fonnum, Frode ^a  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Alzheimer's disease; Amyloid beta protein; Human neutrophil granulocytes; Hydroxyl radical; Hypochlorous acid; Reactive oxygen species

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 HYDROXYBENZOIC ACID; 5 DIETHOXYPHOSPHORYL 5 METHYL 1 PYRROLINE 1 OXIDE; AMYLOID BETA PROTEIN; DIETHYLDITHIOCARBAMIC ACID; DIPHENYLIODONIUM SALT; FLUORESCEIN DERIVATIVE; HYDROXYL RADICAL; HYPOCHLOROUS ACID; LUMINOL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MYELOPEROXIDASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROTOCATECHUIC ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SALICYLHYDROXAMIC ACID; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ADULT; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON SPIN RESONANCE; ENZYME PHOSPHORYLATION; EXPOSURE; FLUORESCENCE ANALYSIS; GRANULOCYTE; HUMAN; HUMAN CELL; HYDROXYLATION; INCUBATION TIME; MALE; NEUTROPHIL; NORMAL HUMAN; REVIEW; SPIN TRAPPING; WESTERN BLOTTING;

ADULT; AMYLOID BETA-PROTEIN; BLOTTING, WESTERN; BUTADIENES; CHELATING AGENTS; DITIOCARB; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENZYME INHIBITORS; FLUORESCEINS; GRANULOCYTES; HUMANS; HYDROXYL RADICAL; HYPOCHLOROUS ACID; LUMINOL; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NADPH OXIDASE; NEUTROPHILS; NITRILES; OXYGEN; PARABENS; PHOSPHOLIPASES A; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SALICYLAMIDES; SIGNAL TRANSDUCTION; SPECTROMETRY, FLUORESCENCE; TIME FACTORS;

EID: 0037363169     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/1071576021000046631     Document Type: Review

References (66)

1. Braak, H. and Braak, E. (1991) "Neuropathological stageing of Alzheimer-related changes", Acta Neuropathol. 8, 239-259.
2. Meda, L., Cassatella, M.A., Szendrei, G.I., Otvos, Jr., L., Baron, P., Villalba, M., Ferrari, D. and Rossi, F. (1995) "Activation of microglial cells by β-amyloid protein and interferon-gamma", Nature 374, 647-650.
3. Johnstone, M., Gearing, A.J. and Miller, K.M. (1999) "A central role for astrocytes in the inflammatory response to β-amyloid; chemokines, cytokines and reactive oxygen species are produced", J. Neuroimmunol. 93, 182-193.
4. van Gool, W.A., Kuiper, M.A., Walstra, G.J., Wolters, E.C. and Bolhuis, P.A. (1995) "Concentrations of amyloid beta protein in cerebrospinal fluid of patients with Alzheimer's disease", Ann. Neurol. 37, 277-279.
5. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D. and Younkin, S. (1996) "Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease", Nat. Med. 2, 864-870.
6. Lue, L.F., Kuo, Y.M., Roher, A.E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J.H., Rydel, R.E. and Rogers, J. (1999) "Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease", Am. J. Pathol. 155, 853-862.
7. Suo, Z., Humphrey, J., Kundtz, A., Sethi, F., Placzek, A., Crawford, F. and Mullan, M. (1998) "Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo", Neurosci. Lett. 257, 77-80.
8. Urmoneit, B., Prikulis, I., Wihl, G., D'Urso, D., Frank, R., Heeren, J., Beisiegel, U. and Prior, R. (1997) "Cerebrovascular smooth muscle cells internalize Alzheimer amyloid β protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy", Lab. Investig. 77, 157-166.
9. Jahroudi, N., Kitney, J., Greenberger, J.S. and Bowser, R. (1998) "Endothelial cell dysfunction in response to intracellular overexpression of amyloid precursor protein", J. Neurosci. Res. 54, 828-839.
10. Blanc, E.M., Toborek, M., Mark, R.J., Hennig, B. and Mattson, M.P. (1997) "Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells", J. Neurochem. 68, 1870-1881.
11. Price, J.M., Chi, X., Hellermann, G. and Sutton, E.T. (2001) "Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production", Neurol. Res. 23, 506-512.
12. McDonald, D.R., Brunden, K.R. and Landreth, G.E. (1997) "Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia", J. Neurosci. 17, 2284-2294.
13. McDonald, D.R., Bamberger, M.E., Combs, C.K. and Landreth, G.E. (1998) "β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes", J. Neurosci. 18, 4451-4460.
14. Klegeris, A. and McGeer, P.L. (1997) "β-Amyloid protein enhances macrophage production of oxygen free radicals and glutamate", J. Neurosci. Res. 49, 229-235.
15. Bianca, V.T., Dusi, S., Bianchini, E., Pra, I.D. and Rossi, F. (1999) "β-Amyloid activates the forming NADPH oxidase in microglia, monocytes, and neutrophiles", J. Biol. Chem. 274, 15493-15499.
16. Knaapen, A.M., Seiler, F., Schilderman, P.A., Nehls, P., Bruch, J., Schins, R.P. and Borm, P.J. (1999) "Neutrophils cause oxidative DNA damage in alveolar epithelial cells", Free Radic. Biol. Med. 27, 234-240.
17. Boyum, A., Lovhaug, D., Tresland, L. and Nordlie, E.M. (1991) "Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality", Scand. J. Immunol. 34, 697-712.
18. LeBel, C.P., Ischiropoulos, H. and Bondy, S.C. (1992) "Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress", Chem. Res. Toxicol. 5, 227-231.
19. Myhre, O., Vestad, T.A., Sagstuen, E., Aarnes, H. and Fonnum, F. (2000) "The effects of aliphatic (n-nonane), naphtenic (1,2,4-trimethylcyclohexane), and aromatic (1,2,4-trimethylbenzene) hydrocarbons on respiratory burst in human neutrophil granulocytes", Toxicol. Appl. Pharmacol. 167, 222-230.
20. Voie, O.A., Wiik, P. and Fonnum, F. (1998) "Ortho-substituted polychlorinated biphenyls activate respiratory burst measured as luminol-amplified chemoluminescence in human granulocytes", Toxicol. Appl. Pharmacol. 150, 369-375.
21. Ste-Marie, L., Boismenu, D., Vachon, L. and Montgomery, J. (1996) "Evaluation of sodium 4-hydroxybenzoate as an hydroxyl radical trap using gas chromatography-mass spectrometry and high-performance liquid chromatography with electrochemical detection", Anal. Biochim. 241, 67-74.
22. Heikkila, R.E. and Cohen, G. (1977) "The inactivation of copper-zinc superoxide dismutase by diethyldithiocarbamate", In: Michelson, A.M., McCord, J.M. and Fridovich, I., eds, Superoxide and Superoxide Dismutases (Academic Press, New York), pp 367-373.
23. Misra, H.P. (1979) "Reaction of copper-zinc superoxide dismutase with diethyldithiocarbamate", J. Biol. Chem. 254, 11623-11628.
24. Davies, B. and Edwards, S.W. (1989) "Inhibition of myeloperoxidase by salicylhydroxamic acid", Biochem. J. 258, 801-806.
25. Ikeda-Saito, M., Shelley, D.A., Lu, L., Booth, K.S., Caughey, W.S. and Kimura, S. (1991) "Salicylhydroxamic acid inhibits myeloperoxidase activity", J. Biol. Chem. 266, 3611-3616.
26. Duncia, J.V., Santella, 3rd., J.B., Higley, C.A., Pitts, W.J., Wityak, J., Frietze, W.E., Rankin, F.W., Sun, J.H., Earl, R.A., Tabaka, A.C., Teleha, C.A., Blom, K.F., Favata, M.F., Manos, E.J., Daulerio, A.J., Stradley, D.A., Horiuchi, K., Copeland, R.A., Schrele, P.A., Trzaskos, J.M., Magolda, R.L., Trainor, G.L., Wexler, R.R., Hobbs, F.W. and Olson, R.E. (1998) "MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products", Bioorg. Med. Chem. Lett. 8, 2839-2844.
27. Favata, M.F., Horiuchi, K.Y., Manos, E.J., Daulerio, A.J., Stradley, D.A., Feeser, W.S., Van Dyk, D.E., Pitts, W.J., Earl, R.A., Hobbs, F., Copeland, R.A., Magolda, R.L., Scherle, P.A. and Trzaskos, J.M. (1998) "Identification of a novel inhibitor of mitogen-activated protein kinase kinase", J. Biol. Chem. 273, 18623-18632.
28. Cohen, N., Weber, G., Banner, B.L., Welton, A.F., Hope, W.C., Crowley, H., Anderson, W.A., Simko, B.A., O'Donnell, M. and Coffey, J.W. (1984) "Analogs of arachidonic acid methylated at C-7 and C-10 as inhibitors of leukotriene biosynthesis", Prostaglandins 27, 553-562.
29. O'Donnell, B.V., Tew, D.G., Jones, O.T. and England, P.J. (1993) "Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase", Biochem. J. 290, 41-49.
30. Gunasekar, P.G., Kanthasamy, A.G., Borowitz, J.L. and Isom, G.E. (1995) "Monitoring intracellular nitric oxide formation by dichlorofluorescin in neuronal cells", J. Neurosci. Methods 61, 15-21.
31. Crow, J.P. (1997) "Dichlorodihydrofluorescein and dihydrohodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species", Nitric Oxide 1, 145-157.
32. Halliwell, B. and Gutteridge, J.M.C. (1999) Free Radicals in Biology and Medicine (Clarendon Press, Oxford).
33. Harrison, J.E. and Schultz, J. (1976) "Studies on the chlorinating activity of myeloperoxidase", J. Biol. Chem. 251, 1371-1374.
34. Izumi, Y., Ogno, K., Murata, T., Kobayashi, H. and Hobara, T. (1994) "Effects of diethyldithiocarbamate on activating mechanisms of neutrophils", Pharmacol. Toxicol. 74, 280-286.
35. Oyama, Y., Furukawa, K., Chikahisa, L. and Hatakeyama, Y. (1994) "Effect of N,N-diethyldithiocarbamate on ionmycin-induced increase in oxidation of cellular 2′′7-dicholofluorescin in dissociated cerebellar neurons", Brain Res. 660, 158-161.
36. Halliwell, B. and Gutteridge, J.M. (1984) "Oxygen toxicity oxygen radicals, transition metals and disease", Biochem. J. 219, 1-14.
37. Halliwell, B. (1993) "The role of oxygen radicals in human disease, with particular reference to the vascular system", Haemostasis 23, 118-126.
38. Coudray, C., Talla, M., Martin, S., Fatome, M. and Favier, A. (1995) "High performance liquid chromatography-electrochemical determination of salicylate hydroxylation products as an in vivo marker of oxidative stress", Anal. Biochem. 227, 101-111.
39. Candeias, L.P., Patel, K.B., Stratford, M.R. and Wardman, P. (1993) "Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorus acid", FEBS Lett. 333, 151-153.
40. Kettle, A.J. and Winterbourn, C.C. (1997) "Myeloperoxidase: a key regulator of neutrophil oxidant production", Redox Rep. 3, 3-15.
41. Clark, R.A., Stone, P.J., El Hag, A., Calore, J.D. and Franzblau, C. (1981) "Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils", J. Biol. Chem. 256, 3348-3353.
42. Schubert, D. and Chevion, M. (1995) "The role of iron in β amyloid toxicity", Biochem. Biophys. Res. Commun. 216, 702-707.
43. Weinberg, E.D. (1992) "Iron depletion: a defense against intracellular infection and neoplasia", Life Sci. 50, 1289-1297.
44. Topham, R.W., Walker, M.C. and Calisch, M.P. (1982) "Liver xanthine dehydrogenase and iron mobilization", Biochem. Biophys. Res. Commun. 109, 1240-1246.
45. phox phosphorylation in human neutrophils", J. Immunol. 165, 5238-5244.
46. Combs, C.K., Johnson, D.E., Cannady, S.B., Lehman, T.M. and Landreth, G.E. (1999) "Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of β-amyloid and protein proteins", J. Neurosci. 19, 928-939.
47. Arendt, T., Holzer, M., Grossmann, A., Zedlick, D. and Bruckner, M.K. (1995) "Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease", Neuroscience 68, 5-18.
48. Shimohama, S., Tanino, H., Kawakami, N., Okamura, N., Kodama, H., Yamaguchi, T., Hayakawa, T., Nunomura, A., Chiba, S., Perry, G., Smith, M.A. and Fujimoto, S. (2000) "Activation of NADPH oxidase in Alzheimer's disease brains", Biochem. Biophys. Res. Commun. 273, 5-9.
49. 2) immunoreactivity is elevated in Alzheimer's disease brain", Neurobiol. Dis. 3, 51-63.
50. 2 is induced in reactive glia following different forms of neurodegeneration", Glia 27, 110-128.
51. Henderson, L.M., Moule, S.K. and Chappell, J.B. (1993) "The immediate activator of the NADPH oxidase is arachidonate not phosphorylation", Eur. J. Biochem. 211, 157-162.
52. Sellmayer, A., Obermeier, H., Danesch, U., Aepfelbacher, M. and Weber, P.C. (1996) "Arachidonic acid increases activation of NADPH oxidase in monocytic U937 cells by accelerated translocation of p47-phox and co-stimulation of protein kinase C", Cell Signal. 8, 397-402.
53. 2 is phosphorylated and activated by MAP kinase", Cell 72, 269-278.
54. Sayre, L.M., Zelasko, D.A., Harris, P.L., Perry, G., Salomon, R.G. and Smith, M.A. (1997) "4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease", J. Neurochem. 68, 2092-2097.
55. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E.K., Jones, P.K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C.S., Petersen, R.B. and Smith, M.A. (2001) "Oxidative damage is the earliest event in Alzheimer disease", J. Neuropathol. Exp. Neurol. 60, 759-767.
56. Prasad, K.N., Hovland, A.R., Cole, W.C., Prasad, K.C., Nahreini, P., Edwards-Prasad, J. and Andreatta, C.P. (2000) "Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale", Clin. Neuropharmacol. 23, 2-13.
57. Mackenzie, I.R. (2000) "Anti-inflammatory drugs and Alzheimer-type pathology in aging", Neurology 54, 732-734.
58. Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S.P., Wu, J.F. and Carney, J.M. (1995) "Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation", J. Neurochem. 65, 2146-2156.
59. Smith, M.A., Richey Harris, P.L., Sayre, L.M., Beckman, J.S. and Perry, G. (1997) "Widespread peroxynitrite-mediated damage in Alzheimer's disease", J. Neurosci. 17, 2653-2657.
60. Price, J.M., Sutton, E.T., Hellermann, A. and Thomas, T. (1997) "Beta-amyloid induces cerebrovascular endotheilia dysfunction in the rat brain", Neurol. Res. 19, 534-538.
61. Niwa, K., Porter, V.A., Kazama, K., Cornfield, D., Carlson, G.A. and Iadecola, C. (2001) "A beta-peptides enhance vasoconstriction in cerebral circulation", Am. J. Physiol. Heart Circ. Physiol. 281, 2417-2424.
62. Thomas, T., McLendon, C., Sutton, E.T. and Thomas, G. (1997) "Cerebrovascular endothelial dysfunction mediated by beta-amyloid", Neuroreport 8, 1387-1391.
63. Reynolds, W.F., Rhees, J., Maciejewski, D., Paladino, T., Sieburg, H., Maki, R.A. and Mashah, E. (1999) "Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease", Exp. Neurol. 155, 31-41.
64. Ihara, Y., Hayabara, T., Sasaki, K., Fujisawa, Y., Kawada, R., Yamamoto, T., Nakashima, Y., Yoshimune, S., Kawai, M., Kibata, M. and Kuroda, S. (1997) "Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia", J. Neurol. Sci. 153, 76-81.
65. Maurizi, C.P. (2001) "Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin", Med. Hypotheses 57, 156-160.
66. Markesbery, W.R. (1997) "Oxidative stress hypothesis in Alzheimer's disease", Free Radic. Biol. Med. 23, 134-147.